Cullen Frost Bankers Inc. Has $277,000 Holdings in CVS Health Co. (NYSE:CVS)

Cullen Frost Bankers Inc. trimmed its holdings in shares of CVS Health Co. (NYSE:CVS - Free Report) by 71.5% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 6,162 shares of the pharmacy operator's stock after selling 15,434 shares during the period. Cullen Frost Bankers Inc.'s holdings in CVS Health were worth $277,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Hotchkis & Wiley Capital Management LLC increased its position in shares of CVS Health by 34.8% during the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 11,897,034 shares of the pharmacy operator's stock worth $748,085,000 after purchasing an additional 3,071,613 shares in the last quarter. ARGA Investment Management LP increased its position in shares of CVS Health by 7,567.7% during the 4th quarter. ARGA Investment Management LP now owns 2,402,901 shares of the pharmacy operator's stock worth $107,866,000 after purchasing an additional 2,371,563 shares in the last quarter. State Street Corp increased its position in shares of CVS Health by 3.6% during the 3rd quarter. State Street Corp now owns 56,527,909 shares of the pharmacy operator's stock worth $3,554,475,000 after purchasing an additional 1,989,066 shares in the last quarter. TOMS Capital Investment Management LP acquired a new stake in shares of CVS Health during the 3rd quarter worth about $121,987,000. Finally, Mizuho Markets Americas LLC increased its position in shares of CVS Health by 1,470.2% during the 3rd quarter. Mizuho Markets Americas LLC now owns 1,396,464 shares of the pharmacy operator's stock worth $87,810,000 after purchasing an additional 1,307,531 shares in the last quarter. 80.66% of the stock is owned by institutional investors.

Remove Ads

CVS Health Trading Up 1.7 %

Shares of NYSE CVS traded up $1.09 during mid-day trading on Friday, hitting $66.34. The company's stock had a trading volume of 10,082,148 shares, compared to its average volume of 11,965,158. The company's fifty day simple moving average is $56.42 and its 200-day simple moving average is $56.75. CVS Health Co. has a one year low of $43.56 and a one year high of $80.75. The stock has a market cap of $83.64 billion, a price-to-earnings ratio of 18.12, a price-to-earnings-growth ratio of 0.98 and a beta of 0.54. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. On average, sell-side analysts anticipate that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 4.01%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health's payout ratio is 72.68%.

Insider Buying and Selling

In related news, Director Michael F. Mahoney purchased 30,000 shares of the business's stock in a transaction on Tuesday, February 18th. The shares were purchased at an average price of $66.70 per share, with a total value of $2,001,000.00. Following the completion of the purchase, the director now owns 39,356 shares in the company, valued at $2,625,045.20. This represents a 320.65 % increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP James David Clark sold 7,513 shares of CVS Health stock in a transaction that occurred on Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total transaction of $498,487.55. Following the completion of the transaction, the senior vice president now directly owns 8,394 shares in the company, valued at approximately $556,941.90. The trade was a 47.23 % decrease in their position. The disclosure for this sale can be found here. 0.24% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on CVS. Piper Sandler dropped their target price on shares of CVS Health from $72.00 to $64.00 and set an "overweight" rating for the company in a research report on Monday, November 25th. Wells Fargo & Company increased their target price on shares of CVS Health from $68.00 to $73.00 and gave the stock an "overweight" rating in a research report on Thursday, February 13th. Evercore ISI raised their price objective on shares of CVS Health from $60.00 to $65.00 and gave the company an "outperform" rating in a research report on Monday, January 27th. Argus set a $77.00 price objective on shares of CVS Health in a research report on Tuesday, February 18th. Finally, Truist Financial raised their price objective on shares of CVS Health from $60.00 to $76.00 and gave the company a "buy" rating in a research report on Thursday, February 13th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $69.83.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.